A Dual Yet Opposite Growth-Regulating Function of Mir-204 and Its Target XRN1 in Prostate Adenocarcinoma Cells and Neuroendocrine-Like Prostate Cancer Cells.

Miao Ding,Biaoyang Lin,Tao Li,Yuanyuan Liu,Yuhua Li,Xiaoyu Zhou,Maohua Miao,Jinfa Gu,Hongjie Pan,Fen Yang,Tianqi Li,Xin Yuan Liu,Runsheng Li
DOI: https://doi.org/10.18632/oncotarget.3480
2015-01-01
Oncotarget
Abstract:Androgen deprivation therapy in prostate cancer (PCa) causes neuroendocrine differentiation (NED) of prostatic adenocarcinomas (PAC) cells, leading to recurrence of PCa. Androgen-responsive genes involved in PCa progression including NED remain largely unknown. Here we demonstrated the importance of androgen receptor (AR)-microRNA-204 (miR-204)-XRN1 axis in PCa cell lines and the rat ventral prostate. Androgens downregulate miR-204, resulting in induction of XRN1 (5'-3' exoribonuclease 1), which we identified as a miR-204 target. miR-204 acts as a tumor suppressor in two PAC cell lines (LNCaP and 22Rv1) and as an oncomiR in two neuroendocrine-like prostate cancer (NEPC) cell lines (PC-3 and CL1). Importantly, overexpression of miR-204 and knockdown of XRN1 inhibited AR expression in PCa cells. Repression of miR-34a, a known AR-targeting miRNA, contributes AR expression by XRN1. Thus we revealed the AR-miR-204-XRN1-miR-34a positive feedback loop and a dual function of miR-204/XRN1 axis in prostate cancer.
What problem does this paper attempt to address?